Biomarkers and Preeclampsia Outcomes
NCT03801447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2022-08-22
Summary
Prospective, observational, monocentric, non-interventional study.
Conditions
Sponsors & Collaborators
-
Maternity Center of Tunis
collaborator UNKNOWN -
Dacima Consulting
lead OTHER
Principal Investigators
-
Dalenda Chelli, MD · Maternité de la Rabta - Tunis
-
Youcef Djedid, MD · Maternité de la Rabta - Tunis
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- Tunisia
Study Locations
More Related Trials
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA
-
Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
NCT03188900 ·Status: COMPLETED
-
Diastolic Dysfunction 2025
NCT07190846 ·Status: COMPLETED
-
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
NCT06403722 ·Status: COMPLETED
-
Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia
NCT06314555 ·Status: COMPLETED
-
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866 ·Status: RECRUITING ·Phase: NA
-
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
NCT07258329 ·Status: RECRUITING
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia
NCT07125599 ·Status: COMPLETED
-
sFlt-1:PlGF Ratio in Diagnosing Superimposed Preeclampsia
NCT03441711 ·Status: COMPLETED
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Cardiac Biomarkers in Preeclampsia: Prediction of Disease and the Risk of Future Cardiovascular Events in Survivors
NCT04468763 ·Status: RECRUITING
-
Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in Preeclampsia
NCT04455204 ·Status: COMPLETED
-
Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
NCT00485784 ·Status: COMPLETED ·Phase: NA
-
Preeclampsia Ratio (sFlt-1/PlGF)
NCT03289611 ·Status: COMPLETED ·Phase: NA
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Novel Biomarkers of Preeclampsia, Aquaporin, Fatty Acid, and S110B
NCT03567551 ·Status: COMPLETED
-
Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
NCT00533871 ·Status: COMPLETED
-
Detection of Epileptiform Activity in Severe Preeclampsia
NCT03494517 ·Status: UNKNOWN
-
Maternal and Fetal Metabolic Changes
NCT06288126 ·Status: COMPLETED
-
Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China
NCT01804751 ·Status: UNKNOWN
-
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282 ·Status: COMPLETED
-
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393 ·Status: UNKNOWN
-
Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease
NCT03231657 ·Status: COMPLETED ·Phase: NA